MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
6.41
+0.04
+0.63%
After Hours: 6.53 +0.12 +1.87% 18:31 05/05 EDT
OPEN
6.30
PREV CLOSE
6.37
HIGH
6.55
LOW
6.16
VOLUME
30.74K
TURNOVER
--
52 WEEK HIGH
11.78
52 WEEK LOW
3.350
MARKET CAP
71.50M
P/E (TTM)
-6.4865
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NTRB last week (0428-0502)?
Weekly Report · 16h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 4d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 5d ago
Earlier Reported: Nutriband CEO Said AVERSA Fentanyl Has The Potential To Become The World's First Opioid Pain Patch With Abuse Deterrent Properties And Is Estimated To Potentially Reach Peak Annual Sales Of $80M-$200M; AVERSA Buprenorphine, Our Next Candidate For Aversa Is Projected To Reach Peak Annual Sales Of $70M-$130M
Benzinga · 5d ago
Nutriband Inc trading halted, volatility trading pause
TipRanks · 5d ago
Nutriband Inc trading resumes
TipRanks · 5d ago
Nutriband issues letter to shareholders
TipRanks · 5d ago
Nutriband Inc reports results for the quarter ended January 31 - Earnings Summary
Reuters · 6d ago
More
About NTRB
More
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Recently
Symbol
Price
%Change

Webull offers Nutriband Inc stock information, including NASDAQ: NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.